Taiwanese Pharmaceuticals & Biotech Big Green Snowflakes

Advagene Biopharma

Market Cap: NT$1.4b

Engages in the research and development of vaccine technology and related products in Taiwan.

Vectorite Biomedical

Market Cap: NT$586.5m

Engages in the research and development of biotechnology in Taiwan and internationally.

Senhwa Biosciences

Market Cap: NT$3.3b

A drug development company, engages in the development of new drugs and targeted agents.

Lin BioScience

Market Cap: NT$12.7b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Enimmune

Market Cap: NT$1.5b

Operates as a biopharmaceutical Research and development, and marketing company in Taiwan.

Medigen Biotechnology

Market Cap: NT$4.1b

A biopharmaceutical company, engages in the research and development of new drugs and vaccines, cytotherapy, advanced nucleic acid testing, generic drugs, aesthetic medicine, and vaccine-related products in Taiwan.

Gwo Xi Stem Cell Applied Technology

Market Cap: NT$2.7b

Develops stem cell medicines for patients with unmet medical needs.

Mercury Biopharmaceutical

Market Cap: NT$3.4b

Engages in the development of drugs for unmet needs in Taiwan.

SynCore BiotechnologyLtd

Market Cap: NT$945.9m

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

Pell Bio-Med Technology

Market Cap: NT$23.0b

A biomedical company, engages in the development of cell culture technologies and techniques for therapeutic applications.

Sinew Pharma

Market Cap: NT$3.6b

A biopharmaceutical company, focuses on the development and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases.

Alar Pharmaceuticals

Market Cap: NT$15.1b

A drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan.

Adimmune

Market Cap: NT$7.6b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

StemCyte International

Market Cap: NT$4.7b

Operates cord blood cell banks in the United States and Taiwan.

BIONET Therapeutics

Market Cap: NT$3.6b

A biopharmaceutical company, develops cell therapy products and drug development for acute and severe diseases.

CHO Pharma

Market Cap: NT$8.0b

Engages in research and development of biotechnology in Taiwan.

PhytoHealth

Market Cap: NT$2.8b

Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.

Lukas Biomedical

Market Cap: NT$1.1b

Engages in the wholesale and retail of cosmetics in Taiwan.

ACRO Biomedical

Market Cap: NT$4.4b

Develops medical-grade regenerative biomaterials.

Medigen Vaccine Biologics

Market Cap: NT$12.6b

A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.

Polaris Group

Market Cap: NT$29.2b

Offers biotechnology, drug testing, and contract development and manufacturing services.

TaiRx

Market Cap: NT$2.8b

Focuses on the development and commercialization of therapeutics for the treatment of cancer and other diseases.

UBI Pharma

Market Cap: NT$1.7b

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.

Tanvex BioPharma

Market Cap: NT$12.6b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

Taho Pharmaceuticals

Market Cap: NT$8.5b

A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.

TaiGen Biopharmaceuticals Holdings

Market Cap: NT$6.8b

A pharmaceutical company, develops novel therapeutics for transformative diseases worldwide.

UnicoCell Biomed

Market Cap: NT$4.7b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

Intech Biopharm

Market Cap: NT$3.1b

Engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally.

General Biologicals

Market Cap: NT$1.0b

Engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

Genomics BioSci & Tech.Ltd

Market Cap: NT$1.8b

Operates as a genomic company in Taiwan.

Sunny Pharmtech

Market Cap: NT$2.6b

Engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally.

Taiwan Advance Bio-Pharmaceutical

Market Cap: NT$1.1b

Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.

Pharmigene

Market Cap: NT$567.7m

Designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.

Gongwin Biopharm Holdings

Market Cap: NT$12.5b

A clinical-stage biopharmaceutical company, develops anticancer drugs.

EirGenix

Market Cap: NT$18.2b

Operates as a contract development and manufacturing company in Taiwan and internationally.

BioGend Therapeutics

Market Cap: NT$5.7b

Researches, develops, and sells orthopedic medical equipment and related products.